These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide. Fletcher S; Honeyman K; Fall AM; Harding PL; Johnsen RD; Wilton SD J Gene Med; 2006 Feb; 8(2):207-16. PubMed ID: 16285002 [TBL] [Abstract][Full Text] [Related]
24. Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy. Porter JD; Merriam AP; Leahy P; Gong B; Feuerman J; Cheng G; Khanna S Hum Mol Genet; 2004 Feb; 13(3):257-69. PubMed ID: 14681298 [TBL] [Abstract][Full Text] [Related]
25. G-utrophin, the autosomal homologue of dystrophin Dp116, is expressed in sensory ganglia and brain. Blake DJ; Schofield JN; Zuellig RA; Górecki DC; Phelps SR; Barnard EA; Edwards YH; Davies KE Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3697-701. PubMed ID: 7731967 [TBL] [Abstract][Full Text] [Related]
26. Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy. Takeshima Y; Yagi M; Wada H; Ishibashi K; Nishiyama A; Kakumoto M; Sakaeda T; Saura R; Okumura K; Matsuo M Pediatr Res; 2006 May; 59(5):690-4. PubMed ID: 16627883 [TBL] [Abstract][Full Text] [Related]
27. Distinct dystrophin mRNA species are expressed in embryonic and adult mouse skeletal muscle. Dickson G; Pizzey JA; Elsom VE; Love D; Davies KE; Walsh FS FEBS Lett; 1988 Dec; 242(1):47-52. PubMed ID: 3060377 [TBL] [Abstract][Full Text] [Related]
28. A novel approach to identify Duchenne muscular dystrophy patients for aminoglycoside antibiotics therapy. Kimura S; Ito K; Miyagi T; Hiranuma T; Yoshioka K; Ozasa S; Matsukura M; Ikezawa M; Matsuo M; Takeshima Y; Miike T Brain Dev; 2005 Sep; 27(6):400-5. PubMed ID: 16122626 [TBL] [Abstract][Full Text] [Related]
29. Dystroglycan mRNA expression during normal and mdx mouse embryogenesis: a comparison with utrophin and the apo-dystrophins. Schofield JN; Górecki DC; Blake DJ; Davies K; Edwards YH Dev Dyn; 1995 Oct; 204(2):178-85. PubMed ID: 8589441 [TBL] [Abstract][Full Text] [Related]
30. Expression of the dystrophin gene in cultured fibroblasts. Hugnot JP; Gilgenkrantz H; Chafey P; Lambert M; Eveno E; Kaplan JC; Kahn A Biochem Biophys Res Commun; 1993 Apr; 192(1):69-74. PubMed ID: 8476435 [TBL] [Abstract][Full Text] [Related]
31. Kainate-evoked changes in dystrophin messenger RNA levels in the rat hippocampus. Górecki DC; Lukasiuk K; Szklarczyk A; Kaczmarek L Neuroscience; 1998 May; 84(2):467-77. PubMed ID: 9539217 [TBL] [Abstract][Full Text] [Related]
32. Characterization of a 4.8kb transcript from the Duchenne muscular dystrophy locus expressed in Schwannoma cells. Blake DJ; Love DR; Tinsley J; Morris GE; Turley H; Gatter K; Dickson G; Edwards YH; Davies KE Hum Mol Genet; 1992 May; 1(2):103-9. PubMed ID: 1301145 [TBL] [Abstract][Full Text] [Related]
33. Determination of qPCR Reference Genes Suitable for Normalizing Gene Expression in a Canine Model of Duchenne Muscular Dystrophy. Hildyard JCW; Taylor-Brown F; Massey C; Wells DJ; Piercy RJ J Neuromuscul Dis; 2018; 5(2):177-191. PubMed ID: 29614692 [TBL] [Abstract][Full Text] [Related]
34. Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy. Araki E; Nakamura K; Nakao K; Kameya S; Kobayashi O; Nonaka I; Kobayashi T; Katsuki M Biochem Biophys Res Commun; 1997 Sep; 238(2):492-7. PubMed ID: 9299538 [TBL] [Abstract][Full Text] [Related]
35. Expression and localization of dystrophin in human cardiac Purkinje fibers. Bies RD; Friedman D; Roberts R; Perryman MB; Caskey CT Circulation; 1992 Jul; 86(1):147-53. PubMed ID: 1617767 [TBL] [Abstract][Full Text] [Related]
36. Quantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient mice. Ghedini PC; Avellar MC; De Lima TC; Lima-Landman MT; Lapa AJ; Souccar C Brain Res; 2012 Nov; 1483():96-104. PubMed ID: 22995368 [TBL] [Abstract][Full Text] [Related]
37. Correction of dystrophin expression in cells from Duchenne muscular dystrophy patients through genomic excision of exon 51 by zinc finger nucleases. Ousterout DG; Kabadi AM; Thakore PI; Perez-Pinera P; Brown MT; Majoros WH; Reddy TE; Gersbach CA Mol Ther; 2015 Mar; 23(3):523-32. PubMed ID: 25492562 [TBL] [Abstract][Full Text] [Related]
38. Tissue distribution of the dystrophin-related gene product and expression in the mdx and dy mouse. Love DR; Morris GE; Ellis JM; Fairbrother U; Marsden RF; Bloomfield JF; Edwards YH; Slater CP; Parry DJ; Davies KE Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3243-7. PubMed ID: 2014247 [TBL] [Abstract][Full Text] [Related]
39. The mouse dystrophin muscle promoter/enhancer drives expression of mini-dystrophin in transgenic mdx mice and rescues the dystrophy in these mice. Anderson CL; De Repentigny Y; Cifelli C; Marshall P; Renaud JM; Worton RG; Kothary R Mol Ther; 2006 Nov; 14(5):724-34. PubMed ID: 16807118 [TBL] [Abstract][Full Text] [Related]
40. Long-term depression is reduced in cerebellar Purkinje cells of dystrophin-deficient mdx mice. Anderson JL; Head SI; Morley JW Brain Res; 2004 Sep; 1019(1-2):289-92. PubMed ID: 15306266 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]